Related Experiment Video
Updated: May 12, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Extracellular adenosine sensing-a metabolic cell death priming mechanism downstream of p53
Jaclyn S Long1, Diane Crighton, James O'Prey
1Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Abstract:
Tumor cells undergo changes in metabolism to meet their energetic and anabolic needs. It is conceivable that mechanisms exist to sense these changes and link them to pathways that eradicate cells primed for cancer development. We report that the tumor suppressor p53 activates a cell death priming mechanism that senses extracellular adenosine. Adenosine, the backbone of ATP, accumulates under conditions of cellular stress or altered metabolism. We show that its receptor, A2B, is upregulated by p53. A2B expression has little effect on cell viability, but ligand engagement activates a caspase- and Puma-dependent apoptotic response involving downregulation of antiapoptotic Bcl-2 proteins. Stimulation of A2B also significantly enhances cell death mediated by p53 and upon accumulation of endogenous adenosine following chemotherapeutic drug treatment and exposure to hypoxia. Since extracellular adenosine also accumulates within many solid tumors, this distinct p53 function links programmed cell death to both a cancer- and therapy-associated metabolic change.
Insights
The tumor suppressor p53 activates a cell death pathway sensing extracellular adenosine. This links cancer metabolism changes to cell death, enhancing tumor eradication.
Area of Science:
- Cellular metabolism
- Cancer biology
- Molecular oncology
Background:
- Tumor cells exhibit altered metabolism to support rapid growth.
- Mechanisms linking metabolic changes to cancer cell death are crucial.
- Extracellular adenosine levels increase with cellular stress and altered metabolism.
Purpose of the Study:
- To investigate the role of the tumor suppressor p53 in sensing metabolic changes.
- To identify pathways that link extracellular adenosine to cancer cell eradication.
- To explore the function of adenosine receptor A2B in p53-mediated cell death.
Main Methods:
- Analysis of p53-mediated upregulation of adenosine receptor A2B.
- Assessment of A2B ligand engagement on cell viability.
- Investigation of caspase- and Puma-dependent apoptotic pathways.
- Evaluation of A2B stimulation in response to chemotherapeutic drugs and hypoxia.
Main Results:
- p53 upregulates the expression of adenosine receptor A2B.
- A2B activation triggers caspase- and Puma-dependent apoptosis.
- Apoptotic response involves downregulation of antiapoptotic Bcl-2 proteins.
- A2B stimulation enhances p53-mediated cell death and chemotherapy-induced apoptosis.
Conclusions:
- p53 links programmed cell death to metabolic changes via extracellular adenosine sensing.
- The p53-A2B axis represents a novel mechanism for cancer cell elimination.
- This pathway connects cancer-associated metabolic alterations to therapeutic strategies.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
13:54Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle